Abstract
Helicobacter pylori infection has a high prevalence in the elderly, but its characteristics and treatment in the geriatric population are not well defined. The aims of the study were to characterize geriatric patients according to referral patterns and results of the 13C-urea breath test (13C-UBT) and to investigate the results of treatment combinations for H. pylori eradiction. The 13C-UBT was performed with 75 mg urea labeled with 13C. Physicians who ordered the test completed a questionnaire covering demographic data, indication for the test, chronic use of a proton pump inhibitor, or nonsteroidal anti-inflammatory drug, and type of eradiction therapy. The study sample consisted of 2128 patients, aged 70–102 years, 958 (45%) men, referred for 13C-UBT. The test was positive on 697 (33%). History of peptic disease was the main indication for referral, following by validation of successful eradication, Israeli origin screening for gastric cancer, treatment with regimen containing metronidazole, history of peptic disease, and recurrence of symptoms were predictive factors for a positive 13C-UBT. Multivariate logistic regression analysis revealed a significant influence of eradication therapy on negative results. History of peptic disease and validation of successful eradication are the main indications for referral of the elderly for 13C-UBT. Our results are in accordance with the increase in metronidazole resistance of H. pylori stains and the cohort effect of H. pylori infection on the elderly Israeli-born population.
Similar content being viewed by others
References
Peterson WL, Graham DY: Helicobacter pylori. In Sleienger & Fordtran’s Gastrointestinal and Liver Disease, 7th ed. Philadelphia, W. B. Saunders, 2002, pp 732–746
Williams MP, Pounder RE: Helicobacter pylori: From the benign to the malignant. Am J Gastroenterol 94 (Suppl):s11–s16, 1999
Asaka M, Sugiyama T, Nobuta A, et al.: Atrophic gastritis and intestinal metaplasia in Japan: Results of a large multicenter study. Helicobacter 6:294–299, 2001
Nakamura M, Haruma K, Kamada T, et al.: Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects. Dig Dis Sci 47:675–681, 2002
Tsukui T, Kashiwagi R, Sakane M, et al.: Aging increases and duodenal ulcer reduces the risk for intestinal metaplasia of the gastric corpus in Japanese patients with dyspepsia. J Gastroenterol Hepatol 16:15–21, 2001
Haruma K, Kamada T, Kawaguchi H, et al.: Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol 15:277–283, 2000
Pilotto A, Salles N: Helicobacter pylori infection in geriatrics. Helicobacter 7 (Suppl 1):56–62, 2002
Brock J, Sauaia A, Ahnen D, et al.: Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease. Results from a quality improvement project. JAMA 286:1985–1993, 2001
Huang JQ, Subbaramiah S, Hunt RM: Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease: A meta-analysis. Lancet 359:214–225, 2002
Chan FKI, To KF, Wu JCY, et al.: Eradication of Helicobacter pylori and rosk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: A randomized trial. Lancet 359:9–13, 2002
Sheu BS, Lee SC, Yang HB, Lin XZ: Quantitative results of 13C urea breath test at 15 minutes may correlate with the bacterial density of H. pylori in the stomach. Hepatogastroenterology 46:2057–2062, 1999
Hawtin PR: Serology and urea breath test in the diagnosis of H. pylori infection. Mol Biotechnol 11:85–92, 1999
Perri F, Clemente R, Pastore M, Quitadamo M, Festa V, Bisceglia M, Li Bergoli M, Lauriola G, Leandro G, Ghoos Y, Rutgeerts P, Andriulli A: The 13C urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Clin Lab Invest 58:19–27, 1998
Cutler AF, Prasad VM: Long term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 91:85–88, 1996
Perez-Perez GI, Culter AF, Blaser MJ: Value of serology as a noninvasive method for evaluation the efficacy of treatment of Helicobacter pylori infection. Clin Infect Dis 25:1038–1043, 1997
Pilotto A, Franceschi M, Leandro G, et al.: Nonivasive diagnosis of Helicobacter pylori infection in older subjects: Comparison of the 13C-urea breath test with serology. J Gerontol A Biol Sci Med Sci 55:M163–M167, 2000
Novis BH, Gabay G, Naftali T: Helicobacter pylori: The Middle East scenario. Yale J Biol Med 71:135–141, 1998
Malfertheiner P, Megraud F, O’Morain C, Hungins APS, Jones R, Axon A, Graham DY, Tytgat G, the European Helicobacter pylori study group (EH.PYLORISG). Current concepts in the management of Helicobacter pylori infection—The Maastricht 2-2000 consensus report. Aliment Pharmacol Ther 16:167–180, 2002
Lind T, Veldhuyzen van Zanten SJO, Unge P: Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials—The MACH 1 study. Helicobacter 1:138–144, 1996
Lind T, Megraud F, Unge P, et al.: The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1 week triple therapies. Gastroenterology 16:248–253, 1999
European Helicobacter Pylori Study Group: Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 41:8–13, 1997
Pilotto A, Franceschi M, Leandro G, et al.: Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. J Gastroenterol Hepatol 14:464–471, 1999
Catalano F, Branciforte G, Brogna A, et al.: Helicobacter pylori-positive functional dyspepsia in elderly patients. Comparison of two treatments. Dig Dis Sci 44:863–867, 1999
Pilotto A, Malfertheiner P: Review article: An approach to Helicobacter pylori infection in the elderly. Aliment Pharmacol Ther 16:683–691, 2002
Pilotto A, Franceschi M, Leandro G, et al.: Cure of Helicobacter pylori infection in elderly patients: Comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. Aliment Pharmacol Ther 15:1031–1036, 2001
Ammon S, Treiber G, Kes F, Klotz U: Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 14:759–766, 2000
Perri F, Villani MR, Festa V, et al.: Predictors of failure of Helicobacter pylori eradication with the standard “Maastricht triple therapy,” Aliment Pharmacol Ther 15:1023–1029, 2001
Meyer JM, Silliman NP, Wang W, et al.: Risk factors for Helicobacter pylori resistance in the United States; The surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993–99. Ann Intern Med 136:13–24, 2002
Younger J, Duggan A: Helicobacter pylori infection in the elderly. Lancet 360:947, 2002 (letter)
Banks L, Wright JP, Marks IN: Peptic ulcer: A follow-up study. J Clin Gastroenterol 8:381–384, 1986
Salles N, Dertheil S, Broutet N, Gras N, Monteiro L, Mascarel MD A, Megraud F, Emeriau J: Detecting Helicobacter pylori infection in hospitalized frail older patients: The challenge. J Am Geriatr Soc 50:1674–1680, 2002
Moayyedi P, Chalmers DM, Axon AT: Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 32:24–27, 1997
Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Alpert LC, Genta RM: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 102:493–496, 1992
Chiba N, Rao BV, Rademaker JW, Hunt RH: Meta-analysis of the efficacy of antibiotic therapy in eradication of Helicobacter pylori. Am J Gastroenterol 87:1716–1727, 1992
Avidan B, Weiss B, Chowers Y, Younash A, Bar-Meir S, Keler N: Sensitivity and resistance of Helicobacter pylori to antibiotic treatment. Harefuah 137:272–274, 1999
Samra Z, Shmueli H, Niv Y, Dinari G, Ofek I, Passaro DJ, Geler A, Gal E, Fishman M, Bachor J, Yahav J: Resistance of Helicobacter pylori isolates in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefoxime. J Antimicrob Chemother 49:1023–1026, 2002
Weisfeld AS, Simmons DE, Vance PH: In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from the multicenter United States clinical trials. Gastroenterology 110:A295, 1996 (abstract)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niv, Y., Niv, G. & Koren, R. 13C-Urea Breath Test for Diagnosis of Helicobacter pylori Infection in the Elderly. Dig Dis Sci 49, 1840–1844 (2004). https://doi.org/10.1007/s10620-004-9581-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-004-9581-4